6-K/A

FORM 6-K/A

Company: NYMOX PHARMACEUTICAL CORP
Filed: June 29, 2023
Period of Report: June 28, 2023
Accession Number: 0001640334-23-001155

View Document ↗ View on SEC.gov ↗